- Home
- ALBT
as 04-25-2025 4:00pm EST
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | FREEHOLD |
| Market Cap: | 5.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 62.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.44 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.11 - $21.60 | Next Earning Date: | 05-30-2025 |
| Revenue: | $486,815 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Avalon GloboCare Corp. News
ALBT Breaking Stock News: Dive into ALBT Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir
GlobeNewswire
18 days ago
Avalon GloboCare Announces Issuance of Patent for Novel CAR-T and CAR-NK Cell Technology in China
GlobeNewswire
a month ago
Avalon GloboCare Partners with Pounds Transformation Clinics to Unveil the KetoAir BrAce 4 Impact Challenge Series
GlobeNewswire
2 months ago
Avalon GloboCare and YOOV, a Leading Business AI Automation Solutions Provider, Enter into Merger Agreement
GlobeNewswire
2 months ago
Fusion Fuel Appoints Luisa Ingargiola to Board of Directors
MT Newswires
2 months ago
Avalon GloboCare Receives Notice of Allowance for Chimeric Antigen Receptor Cell Technology in China
GlobeNewswire
2 months ago
Avalon GloboCare Receives Notice of Allowance for Groundbreaking CAR-T and CAR-NK Cell Technology in China
MT Newswires
4 months ago
Avalon GloboCare Pockets $3.5 Million After Initial Close of Preferred Stock Sale -- Common Shares Slump
Compare ALBT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALBT Avalon GloboCare Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.